Showing results (31-40 of 59) with videos related to
Sort By:
Pageof 6
Epigenomics|June 13, 2015
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insightsSoledad Gómez, Giancarlo Castellano, Gemma Mayol, et al.Pediatric Blood & Cancer|March 28, 2023
Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastomaRosario Aschero, Helena Castillo-Ecija, Merce Baulenas-Farres, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|March 3, 2017
Second re-irradiation for DIPG progression, re-considering "old strategies" with new approachesAndres Morales La Madrid, Vicente Santa-María, Ofelia Cruz Martinez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
A three-gene expression signature model for risk stratification of patients with neuroblastomaIdoia Garcia, Gemma Mayol, José Ríos, et al.Advanced Healthcare Materials|June 13, 2018
Tissue Compatibility of SN-38-Loaded Anticancer Nanofiber MatricesAlejandro Manzanares, Camilo A Restrepo-Perdomo, Gaia Botteri, et al.Molecular Cancer|October 19, 2010
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastomaIdoia Garcia, Gemma Mayol, Eva Rodríguez, et al.Cancer Letters|June 21, 2016
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of disseminationGuillem Pascual-Pasto, Nagore G Olaciregui, Monica Vila-Ubach, et al.BMC Cancer|June 17, 2022
MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironmentLaura Garcia-Gerique, Marta García, Alícia Garrido-Garcia, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 24, 2017
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrierGuillem Pascual-Pasto, Nagore G Olaciregui, Javier A W Opezzo, et al.Pediatric Blood & Cancer|September 22, 2020
Treatment response of CNS high-grade neuroepithelial tumors with MN1 alterationLorena V Baroni, Carlos Rugilo, Fabiana Lubieniecki, et al.Pageof 6